Catalyst
Slingshot members are tracking this event:
Allergan (AGN) Adds to Dermatology Programs in Agreement to Acquire Vitae Pharmaceuticals (VTAE) for ~$639 Million
Do you think this event is important to the companies below? How will it affect their stock price?
Slingshot Insights Explained
Catalyst Date
Occurred on:
Sep 14, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Definitive Agreement, Vtp-43742, Vtp-38543, Contour Drug Discovery Platform, Dermatology Product Pipeline